Business
What Marijuana Reclassification Means For The United States
Washington — The United States Narcotic Enforcement Administration is considering reclassifying marijuana as a less harmful narcotic. The Justice Department’s proposal would recognize cannabis’ medical purposes but not legalize it for recreational use.
The proposal would shift marijuana from the “Schedule I” category to the less stringent “Schedule III.”
So, what does this mean, and what are the implications?
Technically, nothing has happened. The White House Office of Management and Budget must first examine the idea, followed by a public comment period and an administrative judge’s assessment, which could be a lengthy process.
Nonetheless, the change is considered “paradigm-shifting, and it’s very exciting,” Vince Sliwoski, a Portland, Oregon-based cannabis and psychedelics attorney who runs well-known legal blogs on those topics, told The Associated Press when the federal Health and Human Services Department recommended it.
AP – VOR News Image
What Marijuana Reclassification Means For The United States
“I can’t emphasize enough how big of news it is,” he said.
It came after President Joe Biden last year requested that HHS and the attorney general, who controls the DEA, investigate how marijuana was classified. Schedule I legalized it alongside heroin, LSD, quaaludes, and ecstasy, among other substances.
Biden, a Democrat, is in favor of legalizing medical marijuana “where appropriate, consistent with medical and scientific evidence,” White House press secretary Karine Jean-Pierre said on Thursday. “That is why it is important for this independent review to go through.”
No. Schedule III medicines, such as ketamine, anabolic steroids, and several acetaminophen-codeine combos, are still considered controlled narcotics.
AP – VOR News Image
What Marijuana Reclassification Means For The United States
They are subject to a variety of restrictions that allow for some medical usage as well as federal criminal punishment of anyone who traffics in the medications illegally.
Medical marijuana programs, which are already regulated in 38 states, and legal recreational cannabis markets in 23 states are expected to remain unchanged, but they are unlikely to meet federal production, record-keeping, prescribing, and other Schedule III drug criteria.
There haven’t been many federal prosecutions for simply possessing marijuana in recent years, even with marijuana’s existing Schedule I designation, but reclassification would have no immediate impact on those currently in the criminal justice system.
“Put simply, this shift from Schedule I to Schedule III is not keeping people out of jail,” said David Culver, senior vice president of public relations of the United States Cannabis Council.
However, rescheduling would have an impact, especially on research and marijuana business taxes.
Because marijuana is classified as a Schedule I substance, it has been extremely difficult to undertake permitted clinical trials involving its administration. This has produced a Catch-22 situation: there is a need for further study, but there are hurdles to doing so. (Sometimes, scientists rely on people’s claims of marijuana use.)
Schedule III medications are easier to study, although reclassification would take time to remove all hurdles to research.
“It’s going to be really confusing for a long time,” says Ziva Cooper, director of the University of California, Los Angeles Center for Cannabis and Cannabinoids. “When the dust has settled, I don’t know how many years from now, research will be easier.”
Among the unknowns include whether academics will be permitted to study marijuana from state-licensed shops and how the federal Food and Drug Administration would regulate this.
Some researchers remain optimistic.
“Reducing the schedule to schedule 3 will allow us to conduct research with human subjects using cannabis,” said Susan Ferguson, director of the University of Washington’s Addictions, Drug, and Alcohol Institute in Seattle.
Firms involved in “trafficking” marijuana or any other Schedule I or II substance are not allowed to deduct rent, payroll, or other expenses that other firms can. (Yes, despite the federal government’s prohibition on marijuana, at least some cannabis firms, particularly those permitted by states, pay federal taxes.) According to industry associations, tax rates frequently reach 70% or more.
The deduction regulation does not apply to Schedule III medications, so the proposed amendment would significantly reduce cannabis companies’ taxes.
They claim it would treat them like other industries and let them compete with unlawful competitors that frustrate licensees and officials in locations like New York.
“You’re going to make these state-legal programs stronger,” says Adam Goers, an executive at Columbia Care, a medicinal and recreational cannabis provider. He co-chairs a group of corporate and other stakeholders advocating for rescheduling.
According to Beau Kilmer, co-director of the RAND Drug Policy Center, deducting those expenditures could result in greater cannabis marketing and advertising.
Rescheduling would have no direct impact on another marijuana business issue: limited access to banks, particularly for loans, due to federally regulated institutions’ concerns about the drug’s legal status. Instead, the sector has focused on the SAFE Banking Act. It has frequently passed the House but is stuck in the Senate.
AP – VOR News Image
What Marijuana Reclassification Means For The United States
Yes, there are, notably the national anti-legalization organization Smart Approaches to Marijuana. President Kevin Sabet, a former Obama administration drug policy official, said the HHS suggestion “flies in the face of science, reeks of politics” and gives a disappointing nod to an industry “desperately looking for legitimacy.”
Some legalization supporters argue that rescheduling marijuana is too modest. They want to keep the focus on totally removing it from the controlled substances list, which does not include alcohol or tobacco (although they are regulated).
According to Paul Armentano, deputy director of the National Organization for the Reform of Marijuana Laws, simply reclassifying marijuana would be “perpetuating the existing divide between state and federal marijuana policies.” According to Kaliko Castille, President of the Minority Cannabis Business Association, rescheduling simply “re-brands prohibition,” rather than giving state licensees the green light and bringing an end to decades of arrests that disproportionately affected people of color.
“Schedule III is going to leave it in this kind of amorphous, mucky middle where people are not going to understand the danger of it still being federally illegal,” the senator stated.
Peltz reported from New York. Associated Press writers Colleen Long in Washington and Carla K. Johnson in Seattle contributed to this story.
SOURCE – (AP)
Telsa second-quarter profit fell more than 40% from the previous year as the electric car business faced more EV competition from established automakers and a slowing in global EV sales growth.
The decline in income is a dramatic contrast to a corporation that developed to become the world’s most valuable automobile based on rising sales and profitability.
The findings highlight how Tesla, a pioneer in introducing electric vehicles to American drivers, is now facing more domestic and international competition. And as the EV market matures, customer interest in EVs has declined.
Tesla | Auto Guide
Tesla Stock Tumbles After Its Profit Plunged
Tesla (TSLA) shares plunged almost 12% on Wednesday morning, pushing down the broader market. Tesla’s stock was down roughly 1% this year through Tuesday’s close after plunging as much as 44% earlier in the year.
Tesla announced adjusted earnings of $1.8 billion in the quarter or 52 cents per share. Analysts expected 61 cents per share earnings, down from 91 cents the previous year. Its crucial profit margin fell substantially as a series of EV price cuts took its toll.
From April to June, the company had its second consecutive quarter of year-over-year sales decreases and its first consecutive quarter of dropping sales volume. Tesla’s only previous quarterly sales decline since going public occurred early in the pandemic when stay-at-home orders caused its plants to close.
Tesla did not provide a new sales target for the full year. However, it stated: “In 2024, our vehicle volume growth rate may be notably lower than the growth rate achieved in 2023.”
On the investor’s call following the announcement, Tesla CEO Elon Musk criticized the quality of EVs produced by other manufacturers, claiming that it was simply a short-term issue for Tesla and not a long-term one. He added that Tesla is still persuaded that the world is going towards fully electric transportation systems, not just for automobiles, planes, and ships.
Musk also stated that the business would provide more information on fully automated robotaxis in October rather than August as initially intended. The business calls its driver assistance feature “Full Self Driving,” but drivers must still be prepared to take control of the vehicle. According to the company’s earnings statement, Tesla still confronts regulatory and technical challenges before offering self-driving cars.
Musk stated that he still believes it is possible to reach by the end of this year and certainly by next year, but cautioned: “My predictions on this have been overly optimistic in the past.”
Tesla | Top Gear Image
Tesla Stock Tumbles After Its Profit Plunged
The company faces government probes into several of Musk’s boasts about Full Self-Driving capabilities. The company has also been the subject of a Department of Justice investigation, though it is unclear what the current situation is.
However, he disclosed that Tesla’s plans to build an assembly factory in Mexico had been placed on hold. The plans were disclosed more than a year ago, but Musk said they have been halted until after the presidential election due to Republican contender Donald Trump’s vow to impose taxes on Mexican-imported vehicles. Musk is a big Trump booster, having endorsed him and reportedly pledged tens of millions of dollars to the former president’s re-election campaign. Trump promised comparable duties on Mexican-made autos in 2019 but has yet to follow through.
SOURCE – CNN
(VOR News) – Over the Bitcoin course of the last twenty-four hours, the sum of money that has been liquidated in short positions for Bitcoin BTC +4.71% has increased to more than $34 million.
This is a significant increase from the previous state of affairs. The fact that Bitcoin, the digital asset with the highest market capitalisation, has broken beyond the barrier of $67,000 is the reason for this new development.
Nashville, Tennessee will host this year’s Bitcoin Conference.
According to the website of the conference, the former president of the United States is set to make an appearance on the Nakamoto Stage on July 27 at 2:00 p.m. Central Time for a session that will last thirty minutes.
This information is indicated on the website. Yesterday, on the final day of the conference, the session is scheduled to take place.
As a direct result of the increase in the price of bitcoin that took place during the course of the previous day, a total of holdings representing a value of 54 million dollars were sold off.
As a consequence of the increased volatility of the market, the cryptocurrency market as a whole went through liquidations that amounted to more than two hundred million dollars within the same time period. This is evidenced by the data that were provided by Coinglass.
The information that is provided by The Block’s Bitcoin Price Page reveals that the current value of Bitcoin is around $67,330 at the time that this article is being written and published.
This information is provided by The Block. Over the course of the past twenty-four hours, there has been an increase that is greater than five percent.
President Trump will invest in bitcoin by 2024.
Because of the keynote presentation that he will deliver at Bitcoin 2024, Donald Trump will create history by becoming the first candidate for the presidency of the United States of America to visit a conference of this kind that is sponsored by the industry.
This will be something that he will accomplish by attending Bitcoin 2024. In spite of the fact that there is a little amount of information available concerning the specifics of his discussion, the organisers have already claimed that it will be “historic.”
Throughout the course of his presidency, President Trump has adopted a variety of perspectives about a wide range of cryptocurrencies, including bitcoin and others from the same category.
He voiced his disapproval of cryptocurrencies on Twitter in July 2019, saying, “I am not a fan of bitcoin and other cryptocurrencies, which are not money and whose value is highly volatile and based on thin air.”
He was referring to the fact that certain cryptocurrencies are not money. His hatred for these cryptocurrencies has been made clear in his statements.
Specifically, he expressed his discontent with the bitcoin market.
Which was the subject of his expression. This viewpoint was reiterated by him in 2021, when he gave an interview to Fox Business in which he referred to the digital asset as a hoax and voiced his concern that it may compete with the United States dollar or other currencies. In addition, he expressed his concern that it could be used to compete with other currencies.
Nevertheless, throughout the course of the last six months, Trump has rebuilt himself as the “crypto president.” The fact that he chose Ohio Senator JD Vance, who is an investor in bitcoin, to be his vice presidential candidate lends credence to the notion that a Donald Trump presidency may be advantageous to cryptocurrencies.
This is an extra point of interest that is worth mentioning. Bitcoin is an investment that Vance has made.
During the course of the previous day, the dominance of Bitcoin increased slightly to 52.8%, as indicated by the data that were provided by Coingecko. On the other hand, the dominance of ether decreased slightly to 15.5%.
Indicative of the fact that Bitcoin’s dominance rose, both of these data are indicative of reality. After reaching its highest position, the GM 30 Index, which is comprised of a selection of the top 30 cryptocurrencies, witnessed a climb of 3.08% within the same time period, hitting 133.99.
This was after the index had reached its highest peak.
SOURCE: TBN
SEE ALSO:
Sanstar Stock Gains after Listing: Should you Buy, Sell, or Hold?
MMTC’s Shares Surge 20% to Reach a One-Year High; What’s Ahead for This PSU Stock?
Tesla’s Stock is Down due to the Ongoing Decline in Profits.
(VOR News) – Sanstar shares made a quiet Dalal Street debut on Friday, which was less than market participants had anticipated as a consequence of their expectations.
However, the number of buyers rose significantly following the stock’s listing, suggesting that investors are interested in purchasing the company at reduced prices.
At Rs 109 per share, Sanstar shares were offered on the National Stock Exchange (NSE) at a premium of approximately 15%. The stock was listed on the Bombay Stock Exchange (BSE) at a premium of 12 percent over the issue price of Rs 95 per share.
Nevertheless, the stock attained a price of Rs 127.68, achieving a 20% upper circuit and bringing the cumulative profits to 34.4 percent over the price at which it was initially issued.
The majority of analysts continue to maintain a positive outlook on the company and suggest that investors remain invested in the stock for a period of time that varies from medium to long term.
On the other hand, there are some experts who suggest that investors record profits after achieving a respectable profit during the initial trading session.
A successful initial public offering (IPO) was achieved by Sanstar
The company’s shares are currently trading at Rs 109 per share, an increase of 15% from their issue price of Rs 95.
This performance is positive, according to Shivani Nyati, Head of Wealth at Swastika Investmart; however, it fails to satisfy the expectations that were established prior to the listing. The broader market volatility that ensued subsequent to the budget’s announcement was a contributing factor.
Sanstar has been listed, which is a fantastic development, despite the fact that it did not meet the initial hype.
The company’s future expansion is supported by the interest of investors and the company’s robust foundations. Investors have the option to maintain their stake at the issue price, according to her.
Sanstar’s initial public offering (IPO) had the potential to be subscribed between July 19 and July 23, as the business issued its shares at a price range of Rs 90-95 per share, with a lot size of 150 shares.
Sanstar’s follow-on offering yielded a total of Rs 510.15 crore in revenue. This offering comprises a wholly new share sale of up to 397.10 equity shares and an offer-for-sale of up to 1.19 crore equity shares.
Sanstar got a 15% premium because of demand.
Which contributed to the company’s successful launch on the bourses today. According to Prathamesh Masdekar, Research Analyst at StoxBox, Sanstar has established enduring relationships with its consumers and currently serves more than 525 customers, with 162 new customers joining during fiscal year 24.
“The company is committed to expanding its customer base by leveraging the relationships it has established with customers in India and around the world, while simultaneously actively seeking out opportunities to establish new relationships.
“”Because of this, we recommend to the market participants that they keep the shares for a period of time ranging from the medium to the long term,” according to him.
A total of 82.99 subscriptions were received from consumers worldwide for the Sanstar issue. The quota for qualified institutional vendors (QIBs) was satisfied 145.68 times during the auction.
A remarkable 136.50 percent of the quota that was designated for non-institutional investors was subscribed to. The portions that were specified for retail investors were only subject to requests for bids 24.23 times during the three-day bidding procedure.
Sanstar’s listing was lower than anticipated, despite the fact that markets were trending upward. Prashanth Tapse, Senior Vice President of Research at Mehta Equities, maintains that designated investors should record profits on the day of listing, despite the market’s optimistic outlook.
Compared to other listed peers, Sanstar’s valuations are a little higher.
Sanstar is a manufacturer in India that specialises in the manufacturing of plant-based products and ingredient solutions for industrial products, pet food, and food.
Pantomath Capital Advisors served as the exclusive book-running lead manager for Sanstar’s initial public offering (IPO), while Link Intime India served as the registrar.
According to Amit Goel, Co-Founder and Chief Global Strategist at Pace 360, the market volatility in the Indian markets resulted in Sanstar shares failing to meet pre-listing expectations. Sanstar shares were listed on the National Stock Exchange (NSE) at a price of Rs 109.
We strongly recommend that investors take profits in the near term following the completion of the listing. He continues, “It is advised that long-term investors maintain their positions in the company due to its strong fundamentals.”
SOURCE: BTN
SEE ALSO:
MMTC’s Shares Surge 20% to Reach a One-Year High; What’s Ahead for This PSU Stock?
Disney Reaches Tentative Agreement With California Theme Park Workers
Tesla’s Stock is Down due to the Ongoing Decline in Profits.
-
World2 weeks agoFormer President Trump Survives Being Shot at Pennsylvania Rally
-
Tech4 weeks ago
Huawei Launches 5G-A Pioneers Program at MWC Shanghai 2024: Paving the Way for a Connected Future
-
Sports4 weeks ago
NBA Draft: Kyle Filipowski Withdraws Unexpectedly From The First Round
-
Tech4 weeks ago
ChatGPT Answers Undiscovered Questions and Outperforms Students.
-
News4 weeks ago
US Supreme Court Rejects Drug Deal that Protects the Sackler Family
-
Health4 weeks ago
US Health Agency Issues Dengue Virus Infection Warning
